Zevra Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
I think we can get started. I'm Yinglu Zhang, one of the biotech equity research analysts here at RBC Capital Markets. And we're pleased to have Zevra Therapeutics with us today.
Joining us is LaDuane Clifton, Chief Financial Officer. LaDuane, I'll turn it over to you. And thank you for joining us.
Thank you, Yinglu. And good afternoon, everyone. We appreciate you attending our presentation today.
Zevra Therapeutics is a rare disease therapeutics company with a robust pipeline and multiple near-term catalysts and a strong balance sheet to support reaching our objectives. Formerly known as KemPharm, we recently changed our name to Zevra, which is Greek for zebra. The zebra is the internationally recognized symbol of the rare disease community, and by taking that name, Zevra, we have committed ourselves to the mission of bringing new therapies to patients with significant unmet needs.
On this first slide, you can
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
